# A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.

> **NCT02717858** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 52 (actual)

## Conditions studied

- Metabolism and Nutrition Disorder
- Obesity

## Interventions

- **DRUG:** liraglutide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02717858
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-16
- **Primary completion:** 2017-02-27
- **Final completion:** 2017-02-27
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717858, "A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02717858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*